Daniela Shikova

The Benefits and Barriers of Decentralized Clinical Trials

Why does it take so long to get new treatments and vaccines to market?  This topic has been discussed for years now within the clinical research industry with not yet fully established approach on shortening clinical trial timelines, improving recruitment and retention of patients and aligning the research study with what patients want to find …

The Benefits and Barriers of Decentralized Clinical Trials Read More »

The use of connected technologies in clinical research through the years

Over recent years, the adoption of connected technologies has grown dramatically, with a potential for improving health care delivery, research, and patient experience. The increase in wearable technology, availability of smartphones and mobile devices, as well as growth in connectivity, is transforming healthcare all over the world.  Over the past decade, connected technology has flooded …

The use of connected technologies in clinical research through the years Read More »

What is the patient journey of people actively looking for clinical trials?

“85% of clinical trials fail to recruit and retain enough patients in order to meet their enrollment timeline” – a number which we see quite often in analyses, publications, or events presentations within the clinical research industry. With one-third of study budgets going into patient recruitment and hundreds of experienced patient recruitment vendors and experts …

What is the patient journey of people actively looking for clinical trials? Read More »

How Covid-19 impacted patient communities worldwide?

The last few months have been undoubtedly a challenge for the whole society and have left a significant mark in history. Although many industries have been impacted by the Covid-19 pandemic, one of the most impacted sectors has been healthcare.  The coronavirus crisis has brought out many lessons with itself but one of the really …

How Covid-19 impacted patient communities worldwide? Read More »

How to move to virtual clinical trials during Covid-19 (Part 3)

Part 1 | Part 2 Engage with participants Far from creating a sense of remoteness, virtual trials can prevent patients from feeling isolated by creating more timely and personalized touchpoints. Fortunately, existing technologies have paved the way to more engaging interactions with patients and assessment of their overall health and safety. When going virtual, ensure …

How to move to virtual clinical trials during Covid-19 (Part 3) Read More »

How to move to virtual clinical trials during Covid-19 (Part 2)

Return to Part 1 Protect participants and study staff Consider minimizing exposure for study participants and reducing in-person appointments that would require the participant to engage in non-essential travel. Many elements of the study visits can be supported with virtual technologies such as remote monitoring. Patients that are chronically or critically ill and at risk …

How to move to virtual clinical trials during Covid-19 (Part 2) Read More »

How to move to virtual clinical trials during Covid-19 (Part 1)

The majority of clinical trials worldwide are conducted in hospitals or major research institutions, mainly in the bigger cities. This prevents people who live hours away from having the opportunity to take part. Accessibility creates problems for people whose condition doesn’t let them travel or drive or those who are working or having family responsibilities. …

How to move to virtual clinical trials during Covid-19 (Part 1) Read More »

Guidance on the Management of Clinical Trials during COVID-19: How Countries respond

2020 began with a surprise for many people, industries and governments. The coronavirus outbreak turned the world upside down and became a global threat the likes of which we hadn’t experienced for ages. Unfortunately, the clinical research industry was also impacted severely mostly due to the social distancing measures recommended by national and global organisations …

Guidance on the Management of Clinical Trials during COVID-19: How Countries respond Read More »

The Do’s and Don’ts of Direct-to-Patient recruitment

Patient recruitment in clinical research accounts for 32% of trial budgets – the largest single driver of clinical costs. Despite the heavy spending, it remains a huge challenge for the industry and the future of therapeutic innovation causing 50% of delays in clinical trials. Even so, many sponsors still rely on the traditional methods and …

The Do’s and Don’ts of Direct-to-Patient recruitment Read More »

How to refer patients to trials conducted virtually

In recent decades, patients’ interest in participating in traditional on-site clinical trials has diminished and their dissatisfaction has decreased. There are different reasons  – remoteness of clinics and specialists, cumbersome process, financial burden, etc. Although the industry has been discussing a switch to a more remote or virtual way of conducting research studies, this new …

How to refer patients to trials conducted virtually Read More »